SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors digest a string of unfavorable legal verdicts and ongoing concerns regarding AI-related capital expenditures and layoffs. Community discussions are split between those viewing the pullback as a prime dip-buying opportunity given the company's strong cash flow and those expressing deep skepticism, with many traders actively debating the impact of increasing legal scrutiny and long-term business model viability.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing significant volatility as investors debate the impact of a recent short-seller report and ongoing geopolitical tensions on the stock's growth trajectory. While some community members express frustration over recent price declines and dilution concerns, bullish investors remain focused on the company's long-term potential, citing strong fundamentals, the expansion of its Galileo platform, and continued institutional support as key reasons to maintain their positions.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is facing significant downward pressure as market participants weigh broader macro volatility and sector-wide weakness against the company's high growth potential and new AI data partnerships. While some investors are actively accumulating shares based on improving fundamentals and recent insider activity, others are heavily shorting the stock, citing concerns over potential bot-driven metrics and the platform's long-term monetization sustainability.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as investors react to a combination of geopolitical uncertainty and concerns that Googles new memory compression technology might dampen long-term demand for high-bandwidth chips. While some in the community see the sharp pullback as an irrational overreaction and a buying opportunity given the company's strong earnings fundamentals, others are bracing for further volatility, debating whether current price levels signal a bottom or a deeper correction for the broader semiconductor sector.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Market participants are actively debating the potential for an aggressive market correction, driven by fears surrounding the ongoing Middle East conflict and its impact on oil prices, supply chain logistics, and global liquidity. Sentiment remains highly volatile as traders react to conflicting rhetoric from leadership regarding ceasefire negotiations, with many adopting defensive strategies or bearish positions while awaiting further catalysts.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors weigh strong CPU demand and pricing power against broader geopolitical risks and market volatility. The community remains divided, with some traders focusing on technical gap fills and tactical scalping, while others argue over the stock's long-term potential versus concerns regarding its sensitivity to global supply chain disruptions.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to a significant private placement and investor excitement surrounding its INHBE-targeting obesity drug, WVE-007, which is being touted for its potential to drive 'quality' weight loss through visceral fat reduction and muscle preservation. While some community members are bullish on the company's platform and long-term outlook, others are expressing caution regarding recent insider selling and the volatility typical of early-stage biotech trials.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is currently experiencing extreme volatility and intense community frustration following a reverse stock split, with investors aggressively debating whether the move is a setup for a potential short squeeze or a terminal decline. The conversation is dominated by allegations of management silence and mismanagement, while retail traders remain sharply divided between those calling for a mass exit and those holding out for a miraculous turnaround fueled by institutional interest.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the online community debate the company's financial viability and the impact of the ongoing conflict in the Middle East on market stability. Discussion is dominated by heated political discourse, skepticism regarding the firm's revenue models, and concerns over potential stock volatility linked to evolving geopolitical news.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility as investors grapple with escalating geopolitical tensions and a sharp surge in oil prices, prompting intense community debate over whether to "buy the dip" or brace for a deeper structural decline. While some traders view current price levels as a discounted opportunity to accumulate shares ahead of expected AI sector growth, others are warning of significant downside risks, citing the fund's inherent decay and the broader macro uncertainty surrounding the conflict.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rocket Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:RCKT)

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) saw unusually large options trading activity on Thursday. Stock investors purchased 7,425 call options on the stock. This represents an increase of 529% compared to the typical volume of 1,181 call options...

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 9.3% - Should You Buy?

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 9.3% - Here's What Happened...

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Hold" by Brokerages

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have received an average recommendation of "Hold" from the eighteen analysts that are presently covering the firm, Marketbeat...

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.4% - Here's What Happened

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 4.4% - Time to Sell...

Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 4.8% - Should You Sell?

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 4.8% - Here's Why...

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 5.4% - What's Next?

Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Up 5.4% - Time to Buy...

Rocket Pharmaceuticals (NASDAQ:RCKT) Cut to Sell at Wall Street Zen

Wall Street Zen downgraded Rocket Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Sunday...

The Goldman Sachs Group Forecasts Strong Price Appreciation for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock

The Goldman Sachs Group lifted their price target on shares of Rocket Pharmaceuticals from $2.00 to $3.00 and gave the stock a "sell" rating in a research note on Monday...

Brokers Set Expectations for RCKT FY2026 Earnings

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Analysts at Lifesci Capital issued their FY2026 earnings estimates for shares of Rocket Pharmaceuticals in a report released on Thursday...

Lifesci Capital Upgrades Rocket Pharmaceuticals (NASDAQ:RCKT) to Strong-Buy

Lifesci Capital upgraded Rocket Pharmaceuticals to a "strong-buy" rating in a research report on Thursday...

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.

Rocket Pharmaceuticals Inc

ManoJaggarwal bullish call on $MU at $68.07

FinnessaurusFlex bullish call on $ASTS at $1.98

NeverFadeTheOracle bullish call on $SNDK at $41.95

stockwinner1966 bullish call on $USAS at $0.42

Celebrating the single best "called shot" of the year. This award honors a trade that combined timing with conviction, proving that market mastery is an art.

Current Price	$4.95
Prev Close	$4.68
Open	$4.69
Dividend Yield	0.00%
50-Day Moving Average	$4.03
Beta	1.12
Avg. Volume	2.44M
PE Ratio	-2.33

52-Week High	$8.26
52-Week Low	$2.19
Market Capitalization	$508.1M
EPS (Annual)	-$2.01
Price to Book	1.83
Revenue Per Employee	$0.00

RCKT
Rocket Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RCKT News

RCKTRocket Pharmaceuticals Inc